blog

Here at F1000Prime we are grateful for the work of our Faculty; without them we wouldn’t exist. They provide recommendations for articles along with explanations for their choices, identifying key papers week in, week out.

Our Section Heads work hard to ensure the scope of their Sections truly reflect their fields and we are pleased to announce some new appointments.

Faculty of Obstetrics, Gynecology & Women’s Health

Amali Lokugamage will help the three existing Section Heads in overseeing the Psychological Challenges & Issues for Women Section. She is a Consultant Obstetrician and Gynaecologist, Whittington Hospital. Her role covers the Whittington Hospital maternity acupuncture service and the integrated medical gynaecology clinic. Her special clinical interests include normalising birth, maternity acupuncture and holistic gynaecology.

David Eschenbach joins Ronnie Lamont to head up the Gynecologic Inflammation & Infections Section. He is professor and chair of the Department of Obstetrics and Gynecology at the University of Washington School of Medicine. He received his medical doctorate degree from the University of Wisconsin and completed both a residency in obstetrics and gynecology and a fellowship in infectious diseases at the University of Washington before joining the faculty. He is board certified in obstetrics and gynecology.

Faculty of Pharmacology & Drug Discovery

Mario Cazzola has been appointed as the third Head of the Respiratory Pharmacology Section. He is an Honorary Professor of Respiratory Medicine at the University of Rome Tor Vergata. Professor Cazzola is a leading expert on chronic obstructive pulmonary disease (COPD). He has devoted his research to pharmacology of airway diseases. One of his major achievements has been to understand the role of bronchodilators in COPD and the importance of dual bronchodilation.

Stephen B Howell joins Michael Gottesman as Head of the Cancer Therapeutics Section. He is a medical oncologist and Distinguished Professor of Medicine at the University of California, San Diego. Professor Howell is an expert in experimental therapeutics at both the translational and clinical level. His laboratory is focused on the discovery and development of novel chemotherapeutic agents and drug delivery systems as well as the mechanisms by which tumors become resistant to drugs. His primary clinical and research interest is in ovarian carcinoma. Dr Howell attends on the oncology service and runs clinical trials at the Moores UCSD Cancer Center.

We are pleased all have agreed to become a Head of Faculty, and welcome them on board!